The disease spectrum induced by IL-1β is broad and includes microbial infection, autoimmune disorders (Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, etc.), osteoarthritis, neurodegenerative diseases, insulin resistance, and LGI [27,28,29,30]. Here, IL1B is linked to Crohn disease.